Clinical Trial Update: Cardio-fistular Recirculation in Patients With Chronic Heart Failure and Preserved Left Ventricle Ejection Fraction

View source ↗

Summary

A clinical trial investigating cardio-fistular recirculation in patients with heart failure with preserved ejection fraction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Heart Failure with Preserved Ejection Fraction

Snippet

Sponsor: Moscow Regional Research and Clinical Institute (MONIKI) | Conditions: Chronic Kidney Disease 5D, Heart Failure | Status: COMPLETED